Garg Shobit, Khess Christoday R J, Khattri Sumit, Mishra Preeti, Tikka Sai Krishna
Department of Psychiatry, Sri Guru Ram Rai Institute of Medical and Health Sciences, Dehradun, Jharkhand, India.
Deaddiction Centre, Central Institute of Psychiatry, Ranchi, Jharkhand, India.
Ind Psychiatry J. 2018 Jul-Dec;27(2):235-239. doi: 10.4103/ipj.ipj_65_17.
Inability to define the heritable phenotype might be a reason for failure to replicate results in psychiatric genetics. Hence, the use of a candidate symptom approach to identify more homogeneous forms of diseases among affected individuals and subclinical traits among first-degree relatives (FDRs) may increase genetic validity. The objective of the present study was to determine whether physical anhedonia can be used as a marker for individuals at risk of schizophrenia.
Physical anhedonia scores (measured using Revised Physical Anhedonia Scale [rPAS]) were compared across thirty remitted schizophrenic patients, thirty of their unaffected FDRs, and thirty healthy controls. We compared anhedonia scores among the three main groups using one-way ANOVA.
Physical anhedonia (rPAS) scores of the schizophrenic patient group were significantly higher than that of their FDRs and controls both, and physical anhedonia (rPAS) scores of FDRs were significantly higher than that of healthy controls ( = 115.33, < 0.001). The subgroups did not differ on various other clinical characteristics.
Our data suggest that physical anhedonia is a candidate symptom for schizophrenia.
无法定义可遗传表型可能是精神疾病遗传学研究结果无法重复的原因之一。因此,采用候选症状方法来识别受影响个体中更具同质性的疾病形式以及一级亲属(FDRs)中的亚临床特征,可能会提高遗传效度。本研究的目的是确定躯体性快感缺失是否可作为精神分裂症风险个体的标志物。
比较了30名缓解期精神分裂症患者、30名未患病的FDRs以及30名健康对照者的躯体性快感缺失评分(使用修订的躯体性快感缺失量表[rPAS]进行测量)。我们使用单因素方差分析比较了三个主要组之间的快感缺失评分。
精神分裂症患者组的躯体性快感缺失(rPAS)评分显著高于其FDRs和对照组,且FDRs的躯体性快感缺失(rPAS)评分显著高于健康对照组(F = 115.33,P < 0.001)。各亚组在其他各种临床特征上无差异。
我们的数据表明,躯体性快感缺失是精神分裂症的一个候选症状。